Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase

Molecular and Cellular Biology

Volumn 14, Issue 5, 1994, Pages 2883-2894

  Mayer, Bruce J ^a,b   Baltimore, David ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL STRAIN 3T3; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; MUTAGENESIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; VIRUS CELL TRANSFORMATION;

EID: 0028212411     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.14.5.2883     Document Type: Article

References (61)

1. Alexandropoulos, K., R. Ren, W. Pear, P. Cicchetti, and D. Baltimore. Unpublished data.
2. Anderson, D., C. A. Koch, L. Grey, C. Ellis, M. F. Moran, and T. Pawson. 1990. Binding of SH2 domains of phospholipase Cγ1, GAP, and src to activated growth factor receptors. Science 250: 979-982.
3. Ben-Neriah, Y., A. Bernards, M. Paskind, G. Q. Daley, and D. Baltimore. 1986. Alternative 5′ exons in c-abl mRNA. Cell 44:577-586.
4. Birge, R. B., J. E. Fajardo, B. J. Mayer, and H. Hanafusa. 1992. Tyrosine phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze crk-phosphotyrosine-dependent interactions in vitro. J. Biol. Chem. 267:10588-10595.
5. Cicchetti, P., B. J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257:803-806.
6. Cooper, J. A. 1990. The src family of protein-tyrosine kinases, p. 85-113. In B. Kemp and P. F. Alewood (ed.), Peptides and protein phosphorylation. CRC Press, Boca Raton, Fla.
7. Cooper, J. A., and B. Howell. 1993. The when and how of Src regulation. Cell 73:1051-1054.
8. Daley, G. Q., R. A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science 247:824-830.
9. Escobedo, J. A., S. Navankasattusas, W. M. Kavanaugh, D. Milfay, V. A. Fried, and L. T. Williams. 1991. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor. Cell 65:75-82.
10. Foulkes, J. G., M. Chow, C. Gorka, A. R. Frackelton, Jr., and D. Baltimore. 1985. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus. J. Biol. Chem. 260:8070-8077.
11. Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
12. Glenney, J. R., L. Zokas, and M. P. Kamps. 1988. Monoclonal antibodies to phosphotyrosine. J. Immunol. Methods 109:277-285.
13. Gott, S. P., E. Gilboa, O. N. Witte, and D. Baltimore. 1980. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 22:777-785.
14. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phytogeny of the catalytic domains. Science 241:42-52.
15. Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249-270.
16. Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
17. Jackson, P., and D. Baltimore. Unpublished data.
18. Jackson, P. K., M. Paskind, and D. Baltimore. 1993. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene 8:1943-1956.
19. c-src protein to a transforming protein. Mol. Cell. Biol. 6:4155-4160.
20. Koch, C. A., M. F. Moran, I. Sadowski, and T. Pawson. 1989. The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function. Mol. Cell. Biol. 9:4131-4140.
21. Konopka, J. B., R. L. Davis, S. M. Watanabe, A. S. Ponticelli, L. Schiff-Maker, N. Rosenberg, and O. N. Witte. 1984. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. J. Virol. 51:223-232.
22. Margolis, B., N. Li, A. Koch, M. Mohammadi, D. R. Hurwitz, A. Zilberstein, A. Ullrich, T. Pawson, and J. Schlessinger. 1990. The tyrosine-phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-γ. EMBO J. 9:4375-4380.
23. c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. Science 237:411-415.
24. gag-crk to a broad range of phosphotyrosine-containing proteins. Science 248:1537-1539.
25. Matsuda, M., B. J. Mayer, and H. Hanafusa. 1991. Identification of domains of the v-crk oncogens product sufficient for association with phosphotyrosine-containing proteins. Mol. Cell. Biol. 11: 1607-1613.
26. Mayer, B. J., and D. Baltimore. 1993. Signalling through SH2 and SH3 domains. Trends Cell Biol. 3:8-13.
27. Mayer, B. J., and D. Baltimore. Unpublished data.
28. Mayer, B. J., P. K. Jackson, and D. Baltimore. 1991. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl. Acad. Sci. USA 88:627-631.
29. Mayer, B. J., P. K. Jackson, R. A. Van Etten, and D. Baltimore. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12:609-618.
30. McCormick, F. 1993. How receptors turn ras on. Nature (London) 363:15-16.
31. c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 83:9768-9772.
32. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
33. Moran, M. F., C. A. Koch, D. Anderson, C. Ellis, L. England, G. S. Martin, and T. Pawson. 1990. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87:8622-8626.
34. Muller, A. J., A. M. Pendergast, K. Parmar, M. H. Havlik, N. Rosenberg, and O. N. Witte. 1993. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 90:3457-3461.
35. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
36. Panayotou, G., and M. D. Waterfield. 1993. The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 15: 171-177.
37. Pawson, T., and G. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell 71:359-362.
38. Pazin, M. J., and L. T. Williams. 1992. Triggering signalling cascades by receptor tyrosine kinases. Trends Biochem. Sci. 17: 374-378.
39. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
40. Pendergast, A. M., A. J. Muller, M. H. Havlik, R. Clark, F. McCormick, and O. N. Witte. 1991. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88:5927-5931.
41. Ponticelli, A. S., C. A. Whitlock, N. Rosenberg, and O. N. Witte. 1982. In vivo tyrosine phosphorylations of the abelson virus transforming protein are absent in its normal cellular homolog. Cell 29:953-960.
42. c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res. 3:343-355.
43. Reichman, C. T., B. J. Mayer, S. Keshav, and H. Hanafusa. 1992. The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ. 3:451-460.
44. Ren, R., K. Alexandropoulos, and D. Baltimore. Unpublished data.
45. Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a 10-amino acid proline-rich SH3 binding site. Science 259:1157-1161.
46. Renshaw, M. W., E. T. Kipreos, M. R. Albrecht, and J. Y. J. Wang. 1992. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J. 11:3941-3951.
47. src with two tyrosine-phosphorylated cellular proteins. Mol. Cell. Biol. 9:3951-3958.
48. Rotin, D., B. Margolis, M. Mohammadi, R. J. Daly, G. Daum, N. Li, E. H. Fischer, W. H. Burgess, A. Ullrich, and J. Schlessinger. 1992. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cγ. EMBO J. 11:559-567.
49. gag-fps. Mol. Cell. Biol. 6:4396-4408.
50. Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
51. Seidel-Dugan, C., B. E. Meyer, S. M. Thomas, and J. S. Brugge. 1992. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12:1835-1845.
52. Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (London) 315:550-554.
53. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
54. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Shaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
55. Superti-Furga, G., S. Fumagalli, M. Koegl, S. A. Courtneidge, and G. Draetta. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12:2625-2634.
56. Trahey, M., G. Wong, R. Halenbeck, B. Rubinfeld, G. A. Martin, M. Ladner, C. M. Long, W. J. Crosier, K. Watt, K. Koths, and F. McCormick. 1988. Molecular cloning of two types of GAP cDNA from human placenta. Science 242:1697-1700.
57. Valius, M., and A. Kazlauskas. 1993. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73:321-334.
58. Van Etten, R. Personal communication.
59. Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
60. v-src inactivate transformation and modulate membrane stability. J. Virol. 63:291-302.
61. Wang, J. Y. J. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35-43.